Efficacy at 52 weeks of daily clinical use of iguratimod in patients with rheumatoid arthritis.
about
Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat modelIdentification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.Beneficial effects of natural eggshell membrane (NEM) on multiple indices of arthritis in collagen-induced arthritic rats.Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study.Iguratimod prevents ovariectomy‑induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator‑activated receptor‑γ.A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers.Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-κB.
P2860
Q33750865-936708B6-0C40-4936-B19F-DE62467F5D2FQ38735389-0DFC4D1D-7D0A-4624-B1D1-103C39E2B331Q48226254-2E5D117B-3DED-4683-9010-00D395193593Q48744497-F4366F36-0926-4AF5-80F8-D5FD35F80C1BQ49294850-2E40352C-AD2C-4D56-8281-E115A8D7737DQ50100106-40364B32-738A-493B-B27E-BE0CCD30A170Q50108347-9E6095FE-96B4-4587-9598-A77EE08DD15CQ54988132-F18BE628-BC43-4312-9F36-9EE279AE2F0E
P2860
Efficacy at 52 weeks of daily clinical use of iguratimod in patients with rheumatoid arthritis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Efficacy at 52 weeks of daily ...... nts with rheumatoid arthritis.
@en
Efficacy at 52 weeks of daily ...... nts with rheumatoid arthritis.
@nl
type
label
Efficacy at 52 weeks of daily ...... nts with rheumatoid arthritis.
@en
Efficacy at 52 weeks of daily ...... nts with rheumatoid arthritis.
@nl
prefLabel
Efficacy at 52 weeks of daily ...... nts with rheumatoid arthritis.
@en
Efficacy at 52 weeks of daily ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P1433
P1476
Efficacy at 52 weeks of daily ...... nts with rheumatoid arthritis.
@en
P2093
Chisa Okura
Kenji Takagishi
Koichi Okamura
Takahito Suto
Yukio Yonemoto
P2860
P304
P356
10.3109/14397595.2014.998361
P577
2015-02-11T00:00:00Z